Annual Long Term Debt
$2.70 B
+$1.50 M+0.06%
31 December 2023
Summary:
Regeneron Pharmaceuticals annual long term debt is currently $2.70 billion, with the most recent change of +$1.50 million (+0.06%) on 31 December 2023. During the last 3 years, it has risen by +$7.20 million (+0.27%). REGN annual long term debt is now at all-time high.REGN Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$2.70 B
+$400.00 K+0.01%
30 September 2024
Summary:
Regeneron Pharmaceuticals quarterly long term debt is currently $2.70 billion, with the most recent change of +$400.00 thousand (+0.01%) on 30 September 2024. Over the past year, it has increased by +$1.40 million (+0.05%). REGN quarterly long term debt is now at all-time high.REGN Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.1% | +0.1% |
| 3 y3 years | +0.3% | +36.6% |
| 5 y5 years | +281.5% | +279.4% |
REGN Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +36.5% | at high | +36.6% |
| 5 y | 5 years | at high | +281.5% | at high | +279.4% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Regeneron Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.70 B(+0.0%) |
| June 2024 | - | $2.70 B(+0.0%) |
| Mar 2024 | - | $2.70 B(+0.0%) |
| Dec 2023 | $2.70 B(+0.1%) | $2.70 B(+0.0%) |
| Sept 2023 | - | $2.70 B(+0.0%) |
| June 2023 | - | $2.70 B(+0.0%) |
| Mar 2023 | - | $2.70 B(+0.0%) |
| Dec 2022 | $2.70 B(+36.4%) | $2.70 B(+0.0%) |
| Sept 2022 | - | $2.70 B(+0.0%) |
| June 2022 | - | $2.70 B(+0.0%) |
| Mar 2022 | - | $2.70 B(+36.4%) |
| Dec 2021 | $1.98 B(-26.5%) | $1.98 B(+0.0%) |
| Sept 2021 | - | $1.98 B(+0.0%) |
| June 2021 | - | $1.98 B(+0.0%) |
| Mar 2021 | - | $1.98 B(-26.6%) |
| Dec 2020 | $2.70 B(+277.6%) | $2.70 B(+0.0%) |
| Sept 2020 | - | $2.69 B(+276.4%) |
| June 2020 | - | $715.90 M(+0.1%) |
| Mar 2020 | - | $715.20 M(+0.2%) |
| Dec 2019 | $713.90 M(+0.8%) | $713.90 M(+0.2%) |
| Sept 2019 | - | $712.70 M(+0.2%) |
| June 2019 | - | $711.30 M(+0.2%) |
| Mar 2019 | - | $709.90 M(+0.2%) |
| Dec 2018 | $708.50 M(+0.7%) | $708.50 M(+0.2%) |
| Sept 2018 | - | $707.20 M(+0.2%) |
| June 2018 | - | $705.90 M(+0.2%) |
| Mar 2018 | - | $704.64 M(+0.2%) |
| Dec 2017 | $703.50 M(+100.1%) | $703.50 M(+0.2%) |
| Sept 2017 | - | $702.32 M(+0.2%) |
| June 2017 | - | $701.17 M(+0.1%) |
| Mar 2017 | - | $700.41 M(+99.2%) |
| Dec 2016 | $351.57 M(-3.1%) | $351.57 M(-8.0%) |
| Sept 2016 | - | $382.23 M(+5.7%) |
| June 2016 | - | $361.52 M(-0.2%) |
| Mar 2016 | - | $362.23 M(-0.2%) |
| Dec 2015 | $362.92 M(-20.7%) | $362.92 M(-8.1%) |
| Sept 2015 | - | $394.87 M(+1.8%) |
| June 2015 | - | $388.05 M(-17.9%) |
| Mar 2015 | - | $472.48 M(+3.2%) |
| Dec 2014 | $457.71 M(-9.3%) | $457.71 M(-18.9%) |
| Sept 2014 | - | $564.06 M(+9.1%) |
| June 2014 | - | $516.79 M(-2.5%) |
| Mar 2014 | - | $530.05 M(+5.0%) |
| Dec 2013 | $504.57 M(+10.7%) | $504.57 M(+4.8%) |
| Sept 2013 | - | $481.38 M(+1.9%) |
| June 2013 | - | $472.51 M(+2.4%) |
| Mar 2013 | - | $461.27 M(+1.2%) |
| Dec 2012 | $455.95 M(+4.9%) | $455.95 M(+1.2%) |
| Sept 2012 | - | $450.46 M(+1.2%) |
| June 2012 | - | $445.05 M(+1.2%) |
| Mar 2012 | - | $439.74 M(+1.2%) |
| Dec 2011 | $434.53 M(+172.7%) | $434.53 M(+172.5%) |
| Sept 2011 | - | $159.48 M(+0.0%) |
| June 2011 | - | $159.46 M(+0.1%) |
| Mar 2011 | - | $159.35 M(-0.0%) |
| Dec 2010 | $159.35 M(+46.2%) | $159.35 M(+0.6%) |
| Sept 2010 | - | $158.38 M(+0.7%) |
| June 2010 | - | $157.36 M(+0.6%) |
| Mar 2010 | - | $156.46 M(+43.5%) |
| Dec 2009 | $109.02 M | $109.02 M(+74.2%) |
| Sept 2009 | - | $62.57 M(-0.6%) |
| June 2009 | - | $62.92 M(-68.5%) |
| Sept 2007 | - | $200.00 M(0.0%) |
| June 2007 | - | $200.00 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2007 | - | $200.00 M(0.0%) |
| Dec 2006 | $200.00 M(0.0%) | $200.00 M(0.0%) |
| Sept 2006 | - | $200.00 M(0.0%) |
| June 2006 | - | $200.00 M(0.0%) |
| Mar 2006 | - | $200.00 M(0.0%) |
| Dec 2005 | $200.00 M(0.0%) | $200.00 M(0.0%) |
| Sept 2005 | - | $200.00 M(0.0%) |
| June 2005 | - | $200.00 M(0.0%) |
| Mar 2005 | - | $200.00 M(0.0%) |
| Dec 2004 | $200.00 M(0.0%) | $200.00 M(0.0%) |
| Sept 2004 | - | $200.00 M(0.0%) |
| June 2004 | - | $200.00 M(0.0%) |
| Mar 2004 | - | $200.00 M(0.0%) |
| Dec 2003 | $200.00 M(0.0%) | $200.00 M(0.0%) |
| Sept 2003 | - | $200.00 M(-2.5%) |
| June 2003 | - | $205.15 M(+2.6%) |
| Mar 2003 | - | $200.00 M(0.0%) |
| Dec 2002 | $200.00 M(-0.1%) | $200.00 M(0.0%) |
| Sept 2002 | - | $200.00 M(0.0%) |
| June 2002 | - | $200.00 M(-0.0%) |
| Mar 2002 | - | $200.05 M(-0.0%) |
| Dec 2001 | $200.15 M(+9573.8%) | $200.15 M(>+9900.0%) |
| Sept 2001 | - | $1.65 M(-5.9%) |
| June 2001 | - | $1.75 M(-8.6%) |
| Mar 2001 | - | $1.91 M(-7.5%) |
| Dec 2000 | $2.07 M(-23.4%) | $2.07 M(-5.0%) |
| Sept 2000 | - | $2.18 M(-6.8%) |
| June 2000 | - | $2.34 M(-7.3%) |
| Mar 2000 | - | $2.52 M(-6.7%) |
| Dec 1999 | $2.70 M(-12.9%) | $2.70 M(+28.6%) |
| Sept 1999 | - | $2.10 M(-16.0%) |
| June 1999 | - | $2.50 M(-10.7%) |
| Mar 1999 | - | $2.80 M(-9.7%) |
| Dec 1998 | $3.10 M(-18.4%) | $3.10 M(+14.8%) |
| Sept 1998 | - | $2.70 M(-25.0%) |
| June 1998 | - | $3.60 M(+2.9%) |
| Mar 1998 | - | $3.50 M(-7.9%) |
| Dec 1997 | $3.80 M(-25.5%) | $3.80 M(-7.3%) |
| Sept 1997 | - | $4.10 M(-2.4%) |
| June 1997 | - | $4.20 M(-4.5%) |
| Mar 1997 | - | $4.40 M(-13.7%) |
| Dec 1996 | $5.10 M(-15.0%) | $5.10 M(-1.9%) |
| Sept 1996 | - | $5.20 M(+6.1%) |
| June 1996 | - | $4.90 M(0.0%) |
| Mar 1996 | - | $4.90 M(-18.3%) |
| Dec 1995 | $6.00 M(-34.8%) | $6.00 M(-14.3%) |
| Sept 1995 | - | $7.00 M(-9.1%) |
| June 1995 | - | $7.70 M(-10.5%) |
| Mar 1995 | - | $8.60 M(-6.5%) |
| Dec 1994 | $9.20 M(+55.9%) | $9.20 M(+15.0%) |
| Sept 1994 | - | $8.00 M(+11.1%) |
| June 1994 | - | $7.20 M(-11.1%) |
| Mar 1994 | - | $8.10 M(+37.3%) |
| Dec 1993 | $5.90 M(+1.7%) | $5.90 M(-4.8%) |
| Sept 1993 | - | $6.20 M(-1.6%) |
| June 1993 | - | $6.30 M(0.0%) |
| Mar 1993 | - | $6.30 M(+8.6%) |
| Dec 1992 | $5.80 M(+141.7%) | $5.80 M(+11.5%) |
| Sept 1992 | - | $5.20 M(+8.3%) |
| June 1992 | - | $4.80 M(+17.1%) |
| Mar 1992 | - | $4.10 M(+70.8%) |
| Dec 1991 | $2.40 M | $2.40 M(+242.9%) |
| Sept 1991 | - | $700.00 K(+133.3%) |
| June 1991 | - | $300.00 K |
FAQ
- What is Regeneron Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual long term debt year-on-year change?
- What is Regeneron Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly long term debt year-on-year change?
What is Regeneron Pharmaceuticals annual long term debt?
The current annual long term debt of REGN is $2.70 B
What is the all time high annual long term debt for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual long term debt is $2.70 B
What is Regeneron Pharmaceuticals annual long term debt year-on-year change?
Over the past year, REGN annual long term debt has changed by +$1.50 M (+0.06%)
What is Regeneron Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of REGN is $2.70 B
What is the all time high quarterly long term debt for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly long term debt is $2.70 B
What is Regeneron Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, REGN quarterly long term debt has changed by +$1.40 M (+0.05%)